major depression

FDA approves Janssen's fast-acting depression therapy esketamine
FDA approves Janssen's fast-acting depression therapy esketamine
BioCentury
FDA
Spravato
esketamine
Janssen
JNJ
major depression
Flag link:
The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression
The psychiatry field is buzzing with anticipation — and hesitation — about esketamine for depression
Stat
major depression
esketamine
JNJ
FDA
psychiatrists
Flag link:
FDA experts offer a big thumbs up for J&J’s flawed application to market esketamine for major depression — but trial failures, safety questions spur concerns
FDA experts offer a big thumbs up for J&J’s flawed application to market esketamine for major depression — but trial failures, safety questions spur concerns
Endpoints
JNJ
FDA
advisory panels
esketamine
major depression
Flag link:
J&J’s Esketamine for Depression Faces an FDA Panel Next Week
J&J’s Esketamine for Depression Faces an FDA Panel Next Week
BioSpace
JNJ
FDA
esketamine
major depression
Flag link:
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
J&J racks up a fresh set of positive pivotal data for depression drug esketamine — but questions linger on safety
Endpoints
JNJ
esketamine
major depression
Flag link:
Costs Of Treating Those With Diagnosed Depression Eclipses $10,000
Costs Of Treating Those With Diagnosed Depression Eclipses $10,000
Forbes
major depression
healthcare costs
Flag link:
With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine
With hits and misses in first pivotal trials, J&J confidently maps a path to the FDA with its major depression med esketamine
Endpoints
JNJ
esketamine
major depression
Flag link:
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
CP Wire
JNJ
esketamine
depression
major depression
Flag link:
JNJ's Esketamine Demonstrates Significantly Rapid Improvements in Depressive Symptoms and Suicidality in Phase 2 Study
JNJ
esketamine
depression
major depression
Flag link:
J&J’s big blockbuster hopeful esketamine scores high for major depression — but side effects haunt results
J&J’s big blockbuster hopeful esketamine scores high for major depression — but side effects haunt results
Endpoints
JNJ
esketamine
major depression
Flag link:
Depression Drug That Works in One Day Passes Key Test
Depression Drug That Works in One Day Passes Key Test
Forbes
major depression
Naurex
NRX-1074
Flag link: